chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Saturday, 07/30/2021, I started feeling a sore throat, fever, upper respiratory symptoms. The next night, 07/31/2021, I tested positive for Covid via a BinaxNow home test.  These results were confirmed through Urgent Care via a PCR nasal swab test on Sunday, 08/01/2021.  My fever ran off and on for 10 days, my upper respiratory symptoms were very severe - shortness of breath, coughing, stuffiness, severe bronchitis-type symptoms making it difficult to lay down without coughing.  I had a sore throat for 3 days and headaches off and on for 4-5 days, beginning 07/31/2021.  I suffered with fatigue, insomnia, and lack of physical stamina.  The worst of my symptoms did not abate for 14 days and on day 16, I started coughing up blood with mucus from my lungs  My doctor then ordered a CT scan (with contrast) to ensure I did not have blood clots in my lungs or pneumonia because I had been sick/coughing for so long.  I was negative for both blood clots and pneumonia and was given a steroid inhaler to assist with my breathing.  The shortness of breath/fatigue/lack of physical stamina continued for nearly 2 months, after testing positive for Covid-19 on 07/31/2021.  I went from being very physically active before contracting Covid (with no breathing issues) to being unable to even shower without feeling winded, post Covid.
dizzy with tingling hands soon after injection (10 minutes after). seemed to improve during observation and I left.  Started to itch and took benadryl and Tylenol approx. 2 hours after dose received.  Had swelling of joints (knees, ankles, neck and shoulders were all imflamed and stiff).  Injection sites swelled, red and hot until Sunday afternoon. Iced on and off the two previous days. Took benadryl again on Saturday because rash formed on chest, and eczema flared up.  Today, Wed, 2-10-21, rash is still present on chest but is improving. eczema is still flared up.
Approximately 5 x 15 cm erythematous, warm reaction around the injection site on the right shoulder. Tylenol, and ibuprofen. RTC if worsening or changing symptoms, if experiencing fevers, or if no improvement over the next 5 days.
fever, 101.7F, headache, chills, left arm  sore after shot
Received expired vaccine > 12 hours after first puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine > 12 hours after first puncture) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine > 12 hours after first puncture). On 01-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine > 12 hours after first puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.
Achy; Nausea; hot and cold, 99temp at times; Bumps and burning in my mouth; Bumps and burning in my mouth; Ears ringing; Large bruise at injection sight.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old unknown gender patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included pancreatitis. The patient received unspecified medication within two weeks of vaccination. The patient previously took Atropine on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:00 the patient experienced achy, nausea, hot and cold, 99temp at times, bumps and burning in mouth, ears ringing and large bruise at injection sight. Bruised lasted still after 1 week. On 31Mar2021, the patient underwent lad test and procedures, which included body temperature and the result was 99temp. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events achy, nausea, hot and cold, bumps and burning in mouth, ringing ears and bruise at injection site was not recovered.   No follow-up attempts are needed. No further information is expected.
if the changes in his temperature are normal or not.; This is a spontaneous report from a contactable consumer (patient, self-reporting). A male patient of an unspecified age received first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 23Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient stated that he got the first dose yesterday, and he was asking if the changes in his temperature are normal or not. The patient underwent lab tests and procedures which included body temperature: changes in his temperature on Feb2021. Outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
I still have redness, bruising and the area is warm to the touch at the injection site.  I am having pain in the underarm and going into the chest area.  Have not been treated ... I did tell the people who are doing the texting about the results of the shot.  I have not seen anyone about the problem.  Since I had not received any text referencing the problem I assumed it was standard.
Patient experienced a rash around the injection site and the patient's lips swelled up. Patient contacted the Dr who instructed patient to take her prescription of Xyzal at which time the symptoms resolved.
Pt.'s arm started to get painful around bedtime on 4/15/15. Pt. noticed some redness and swelling at site. Site warm to touch and red. Area of redness is from top of shoulder to almost elbow, 8 inches and width of redness is 6 inches wide at widest point of muscle. Pt. states tender to touch.
PAIN IMMEDIATELY AFTER SHOT FROM SITE OF INJECTION DOWN ARM AND INTO RING FINGER, WEIRD NUMBING PAIN, LIKE WHEN YOU HIT YOUR FUNNY BONE BUT THE FEELING DID NOT SUBSIDE FOR A WEEK AFTER THE SHOT.
Diarrhea and nausea onset approx 36hrs after receiving vaccine. Diarrhea worsened. Covid test taken to rule out illness. Doctor seen for treatment. Treated with Flagyl. Called from clinic on Friday and told to get stool sample for culture. Given collection kit. Discussed instructions with lab tech. Sample taken to Hospital. Hospital states no orders from doctor.  Unable to contact doctor because of weekend. Later, stool began to firm up slightly and began to feel like it was getting better although still very weak and lethargic. Took another 1-2 weeks to recover.
Redness of skin, hot to touch, fever on right arm on 9/27/13 (2 days after vaccine administration). Dx = cellulitis, given Rx for SEPTRA.
This spontaneous report as received from a physician via a field employee refers to a male patients of 16-18 age. The patient was vaccinated intramuscularly with 0.5 ml GARDASIL (lot# was unknown) on 08-AUG-2012 and passed out after vaccinated. The patient sought medical attention. The doctor doesn't believe that it was due to the vaccine, he believed it was because the patient were nervous about getting shot in general. The outcome of passed out was unknown. The doctor didn't want to be contacted regarding this AE. Upon internal review, the pass out was considered as medically significant. This is one of the same report received from the same source. Additional information is not expected.
Patient received J&J vaccine 3/30/21 4/21/21 Presented to hospital with syncope and collapse, work-up for NSTEMI and placed on heparin infusion Patient found to have RLE DVT and bilateral PE with right heart strain.  Platelet decreased and patient started on argatroban infusion. HIT negative, platelets remaind stable. Discharged 4/25/21 on apixaban
After giving the vaccine, patient felt dizzy, nausea, and shaking (arms and legs). After 30 mins she felt good.
Information has been received from a nurse practitioner concerning a healthy, 44-year-old, female medical technologist, with a history of penicillin allergy who on 01-MAR-2007 at 10:00 am was vaccinated subcutaneously with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (lot # 654693/1052F) (also reported as "1025F"). Concomitant therapy included Lamisil. On 02-MAR-2007, 24 hours after vaccination, the patient experienced localized injection site swelling, which continued to swell and developed into a lump. Her whole upper arm eventually became swollen, red, pruritic, warm, painful and tender. Medical attention was sought. The patient self-medicated with Benadryl and ice packs. The patient recovered on 05-MAR-2007. No further information available. There was no product quality complaint involved. Follow up information indicated that on 03-Mar-2007, the patient's right tricep region swelled, was warm and itchy. It was a localized reaction. The patient recovered on 06-Mar-2007. It is unspecified if medical attention was sought. It is also reported that on an unspecified date the patient received a flu shot and experienced a localized reaction.
12-14 hours after vaccine patient developed itchy rash on arm that spread to neck, trunk and legs
This spontaneous report was received from a licensed vocational nurse refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 21-OCT-2015, the patient was vaccinated with a dose of VARIVAX, lot # L006383 and expiration date 25-MAR-2017 (dose, route of administration and anatomical location were not provided). There were no concomitant medications reported. No adverse effect was reported. No product quality issue was involved. This is one of several cases from the same reporter. Additional information has been requested.
Pt developed a rash about an 30mins to an hour after receiving vaccine. Pt took Loratadine & Benadryl. Next day pt felt better. Soreness @ inj. site.
injection site swelling, redness, pain; injection site swelling, redness, pain; injection site swelling, redness, pain; This is a spontaneous report from a contactable other health professional. A 56-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EL3249, intramuscular, in the right arm, on 05Feb2021 10:00 at SINGLE DOSE for covid-19 immunization. Medical history included allergies (unspecified). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. The patient's concomitant medications were not reported. The patient experienced injection site swelling, redness, pain on 05Feb2021 10:00. The outcome of event was unknown. Patient did not receive any treatment for the events.  No follow-up attempts possible. No further information expected.
Feeling pretty achy; muscle aches; Flu like symptoms; Soreness at injection site; felt crummy; felt like she was coming down with something; This case was reported by a other health professional via call center representative and described the occurrence of pain in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (she had an active case of shingles at 35 years old), skin lesion (had right sided might be the L4-L5 S1 dermatome skin lesions), abdominal pain (Deep right lower abdomen pain), appendicitis and neuralgia (post neuralgia pain). Previously administered products included Acyclovir.   On 31st January 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than a year after receiving Shingrix, the patient experienced pain, muscle pain, influenza-like symptoms, injection site pain, feeling bad and feeling unwell. On an unknown date, the outcome of the pain, muscle pain, influenza-like symptoms, injection site pain, feeling bad and feeling unwell were recovered/resolved.   It was unknown if the reporter considered the pain, muscle pain, influenza-like symptoms, injection site pain, feeling bad and feeling unwell to be related to Shingrix.  Additional details were provided as follows: Following 1st dose of the vaccine, the patient felt pretty achy, had muscle aches, flu like symptoms, soreness at the injection site, felt crummy and felt like she was coming down with something.  The patient experienced this for 24 to 48 hours and then resolved. The patient received 2nd dose and experienced some adverse events, for tolerance refer the case US2019124837.
Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest; Woke up on the floor out of his bed; Pain; Right collar bone hurts; Neck hurts; Feels like he was attacked in the middle of the night; Right arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts) and NECK PAIN (Neck hurts) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event history). Concomitant products included LORATADINE, ALBUTEROL SULFATE, OLODATEROL HYDROCHLORIDE, TIOTROPIUM BROMIDE MONOHYDRATE (STIOLTO RESPIMAT), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), ASCORBIC ACID (VIT C), CALCIUM CARBONATE, FERROUS SULFATE, MALUS SPP., ZINC CITRATE, ZINC SULFATE (MULTIVIT [CALCIUM CARBONATE;FERROUS SULFATE;MALUS SPP.;ZINC CITRATE;ZINC SULFATE]) and OMEPRAZOLE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts), NECK PAIN (Neck hurts), FEELING ABNORMAL (Feels like he was attacked in the middle of the night) and PAIN IN EXTREMITY (Right arm hurts). At the time of the report, NIGHTMARE (Bad nightmare, feels like someone beat the hell out of him, feels like he was kicked in the chest), SLEEP DISORDER (Woke up on the floor out of his bed), PAIN (Pain), BONE PAIN (Right collar bone hurts), NECK PAIN (Neck hurts), FEELING ABNORMAL (Feels like he was attacked in the middle of the night) and PAIN IN EXTREMITY (Right arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
p/vax pt started fever 102-103; & devel suboccipital; lymphadenopathy rt then minimal rash; 8/21 few maculopapules/small
I developed an immediate headache with 5-10 minutes that subsided after 15-20 minutes. Started feeling muscles achy after about an hour and feeling punky, at 2:45 minutes post IM feeling flushed ensued with red face and glassy eyes, needing to sit down due to fatigue , very thirsty, then joint pains especially feet making standing and walking prolonged painful, started with slight cough took advil and needed to go home from work by 3:30 minutes post receiving vaccine. SOB ,4 pillow orthopnea at hour 4-5 , needed prednisone by evening and duo neb by morning. Drenching swets all night.
It was swelling; 4 inches by 4 inches red; arm started to be sore; arm started to be sore and itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm started to be sore), PRURITUS (arm started to be sore and itchy), PERIPHERAL SWELLING (It was swelling) and VACCINATION SITE ERYTHEMA (4 inches by 4 inches red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm started to be sore) and PRURITUS (arm started to be sore and itchy). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (4 inches by 4 inches red). On an unknown date, the patient experienced PERIPHERAL SWELLING (It was swelling). At the time of the report, PAIN IN EXTREMITY (arm started to be sore), PRURITUS (arm started to be sore and itchy), PERIPHERAL SWELLING (It was swelling) and VACCINATION SITE ERYTHEMA (4 inches by 4 inches red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient developed rash at her right side of body and saw doctor on 5/15/12 and her doctor confirmed she had shingles and prescribed Acyclovir 800 mg and she's now recovered.
Swollen lymph node underneath right arm the size of a golf ball.  Painful and numb
pain all over the body, swelling of neck, axilla and arm, pain on left side of arm.
Administrative deviation only; no adverse event resulted from this deviation.This patient received a  mixed series of COVID-19 vaccine (one dose of Moderna and one dose of Pfizer-box#4 reflects the date of the second dose).The decision to administer a mixed series to the patient was due to an "exceptional  circumstance "  stemming from the unavailability of the first vaccine product (Moderna) at the time the  second dose was due.We understand that although CDC provides considerations for a mixed series in  exceptional circumstances (such as a vaccine shortage, which was the case here),a mixed series is still  considered an administration deviation that requires VAERS reporting.Note second vaccination date is  listed.
12/16/16 at 1400PM received 3 vaccinations below in Right upper arm. Awoke morning of 12/18/16 at 0700 with itch and redness on under side of Right arm. Area settled down over next 2 days. Declined 2nd MMR vaccination due 1/13/2017. Recheck on Mumps titer 2/27/17 proved (+) Immuno Response.
Left deltoid with 2" x 2" red area over immunization site given antibiotic and antihistamine.
Client reported "burning" in his arm around the vaccination site immediately after receiving the COVID vaccine. The client reported "numbness" around the deltoid where he received the COVID vaccine. No noted redness or swelling around the site. At 1:35PM the client reported a headache, stomachache, and left arm pain from his elbow to shoulder. The client described the arm pain similar to sore muscle pain. The client denied any s/s of anaphylaxis. The client stated "I feel the food in my stomach." Vitals obtained at 1:38 PM were as follows BP 141/84, HR 95, and O2 98%. The client stated he went to bed at 2:00AM last night and did drink water this morning. At 1:40PM the client requested, was provided, and began consuming a snack and juice. At 1:48PM the client said, "I feel good." Vitals obtained at 1:49PM were as follows: automatic BP 172/73, HR 95, and O2 98%. Noted the automatic BP cuff was placed incorrectly. Repeat automatic BP obtained at 1:532PM was 151/82. At 2:03 the client reported that his arm was still sore but his headache was improving. The client denied any dizziness, nausea, or chest pressure. Vitals obtained at 2:03PM were as follows: automatic BP 162/83, HR 90, O2 97%. At 2:07PM education was provided to client and his mother regarding elevated BP, s/s of anaphylaxis, when to seek EMS. The client and his mother voiced understanding of this. The client stated that he felt nervous. Recommended the client and his mother follow up with PCP regarding elevated BP. Client's mother voiced understanding of this education. Assessed upper extremity strength, which was equal bilaterally. Assessed facial nerve function which was equal bilaterally. The client denied any shortness of breath, dizziness, or itching. Examined the vaccination site, and noted no redness or swelling. Manual BP obtained at 2:09PM was 150/86. Vitals obtained at 2:24PM were as follows: manual BP: 150/78, HR 86, and O2 96%. Offered to call EMS to evaluate the client. The client's mother declined EMS at 2:29PM.
Sudden total hearing loss in left ear; This is a spontaneous report from a contactable consumer (patient). A 49-year-old male patient received third dose of bnt162b2 via an unspecified route of administration, administered in left arm on 15Oct2021 at 15:30 (Batch/Lot number was not reported, unable to locate or read the details) at age of 49-year-old as single booster dose for covid-19 immunisation; first dose of influenza vaccine inact split 3v (AFLURIA), via an unspecified route of administration, administered in right arm on 15Oct2021 (Batch/Lot number was not reported) at age of 49-year-old as single dose for an unspecified indication. The patient previously took first dose of bnt162b2 (Batch/Lot number was unknown) via an unspecified route of administration, administered in left arm on 21Dec2020 at 16: 30 at age of 48-year-old for covid-19 immunisation, second dose of bnt162b2 (Batch/Lot number was unknown) via an unspecified route of administration, administered in left arm on 25Jan2021 at 13: 00 at age of 48-year-old for covid-19 immunisation. The patient had known allergies with Codeine. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered was pharmacy or drug store. Concomitant medication included omeprazole. The patient experienced sudden total hearing loss in left ear on 23Oct2021 at 23:30. Seriousness criteria were reported as disabling/ incapacitating. The event was resulted in Doctor or other healthcare professional office clinic visit Emergency room department or urgent care Disability or permanent damage. Treatment included high dose steroid. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. The outcome of event was not recovered.  The lot number for the vaccine BNT162B2, was not provided and will be requested during follow up.
This case was reported by a pharmacist via a sales representative and described the occurrence of injection site pain in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date the subject received a dose of FLUARIX. Less than one day after vaccination with FLUARIX, the subject experienced injection site pain. The next day, the area was hard and a blister formed. It was reported that it took a week for the events  to resolve. The reporter indicated that this event occurred with seven patients that received FLUARIX. Linked cases include A0950541A, A0950542A, A0950543A, A0950544A, A0950545A and A0950546A.
1. Delayed/late menstrual cycle. My periods were very regular. Last period 5/11/21.  Around the first dose I should have started my period. As of today, my period has still not started. Since the vaccine I am 20 days late, and not pregnant.   2. External numbing of both arms and face (lasted 5 days)  3. Brain fog, malaise (lasted 3 days)
15JAN93 t103, diarrhea, vomiting, lethargic, rash on stomach; 17JAN93 mom reports rash all over body; 19JAN93 seen by nurse-rash on neck & face-diarrhia, vomiting or fever;